glp-1 stomach paralysis class action in michigan semaglutide gastric stasis legal team gastric stasis michigan GLP-1 Drugs And Gastroparesis: What Patients Should Companies making Ozempic and Mounjaro

StatPearls (Internet)

Semaglutide 2.4 mg for managing overweight and obesity (TA875)

In the GLP-1 vs DPP-4 inhibitor cohort (2009-2022), we identified 108,322 new users of GLP-1 RAs and 55,411 new users of DPP-4 inhibitors using the National Prescription Registry

Subcutaneous deposition was also an important part of the mechanism of protraction here, facilitated by the fatty acid in insulin degludec leading to self-assembly into multi-hexamers, but insulin degludec also has a longer intravenous half-life than insulin detemir (26)

Some retention is expected, but dramatic puffiness or rapid weight gain from fluid warrants dose reduction